Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-817MA in mild to moderate Alzheimer's disease
NCT00663936Phase 2Completed
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Apr 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing T-817MA with Placebo (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 52 weeks. Started Apr 2008; status: completed.
02
Drugs
edonerpic
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00663936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663936.